241
Participants
Start Date
March 4, 2021
Primary Completion Date
April 7, 2023
Study Completion Date
December 31, 2027
Axatilimab
Axatilimab is a high-affinity antibody targeting the colony stimulating factor 1 receptor (CSF-1R). CSF-1R signaling has been demonstrated in nonclinical studies to be the key regulatory pathway involved in the expansion and infiltration of donor-derived macrophages that mediate the disease processes involved in cGVHD.
National Taiwan University Hospital, Taipei
Fondazione Policlinica Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Roma
The Royal Children's Hospital, Parkville
Hospital Clinic Barcelona, Barcelona
Weill Medical College of Cornell University, New York
Stony Brook University Medical Center, Stony Brook
University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
Complejo Hospitalario Universitario de Granada - Hospital Universitario Virgen de las Nieves, Granada
Children's National Medical Center, Washington D.C.
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan
IRCCS Ospedale San Raffaele, Milan
University of Virginia Medical Center, Charlottesville
University General Hospital of Patras, Pátrai
Fondazione IRCCS Policlinico San Matteo, Pavia
Wake Forest, Winston-Salem
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario Ramon y Cajal, Madrid
Hospital Universitario La Paz, Madrid
Emory University, Atlanta
Northside Hospital, Atlanta
IUCT-Oncopole, Toulouse
Mayo Clinic - Jacksonville, Jacksonville
University of Florida (UF), Gainesville
AdventHealth Orlando, Orlando
University of Miami, Miami
Moffitt, Tampa
University of Alabama at Birmingham - Children's of Alabama, Birmingham
University of Alabama at Birmingham, Birmingham
Hospital Clinico Universitario de Salamanca, Salamanca
Vanderbilt University Medical Center, Nashville
CHU de Grenoble, La Tronche
China Medical University Hospital, Taichung
Hospital Universitario Virgen del Rocio, Seville
The Ohio State University Comprehensive Cancer Center, Columbus
University Hospitals Cleveland Medical Center, Cleveland
The Cleveland Clinic Foundation, Lyndhurst
Cincinnati Children's Hospital Medical Center, Cincinnati
Hospital Clinico Universitario de Valencia, Valencia
Hospital Universitari i Politecnic La Fe, Valencia
Indiana University Health Melvin and Bren Simon Cancer Center, Indianapolis
Franciscan Health Indianapolis, Indianapolis
University of Michigan, Ann Arbor
Universitaetsklinikum Muenster, Münster
Barbara Ann Karmanos Cancer Institute, Detroit
Henry Ford Hospital, Detroit
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
University of Wisconsin - Carbone Cancer Center, Madison
Universitaetsmedizin der Johannes Gutenberg - Universitaet Mainz, Mainz
University of Minnesota, Minneapolis
Mayo Clinic - Rochester, Rochester
General Hospital of Thessaloniki G. Papanikolaou - Hematology Department, BMT Unit, Eksochi
CHRU de Lille - Hopital Claude Huriez, Lille
The University of Chicago Medical Center (UCMC), Chicago
Washington University School of Medicine, St Louis
Institut de cancérologie Strasbourg Europe (ICANS), Strasbourg
Tulane University Medical Center, New Orleans
University of Oklahoma - Health Sciences Center, Oklahoma City
Hopital Saint Louis, Paris
Hopital Pitie Salpetriere, Paris
MD Anderson Cancer Center, Houston
CHU Amiens Picardie - Hopital Sud, Amiens
Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City
Intermountain Healthcare, Salt Lake City
University of Utah, Salt Lake City
University of Southern California Norris Comprehensive Cancer Center, Los Angeles
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
City of Hope, Duarte
Universitatsklinikum Regensburg, Regensburg
Stanford Cancer Center, Stanford
Oregon Health & Science University, Portland
Fred Hutchinson Cancer Research Center, Seattle
National University Hospital, Singapore
KK Women's and Children hospital, Singapore
Rambam Health Care Campus, Haifa
Chaim Sheba Medical Center, Ramat Gan
Tel Aviv Sourasky Medical Center, Tel Aviv
Hadassah Medical Center Ein Karem, Jerusalem
Johns Hopkins Kimmel Cancer Center, Baltimore
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
University of Massachusetts Memorial Medical Center, Worcester
Rutgers Cancer Institute of New Jersey, New Brunswick
Westmead Hospital, Westmead
Universitaire Ziekenhuizen Leuven, Leuven
AZ Delta, Roeselare
Princess Margaret Hospital, Toronto
CHRU de Nancy - Hôpitaux de Brabois, Nancy
CHU de Nantes - Hôtel-Dieu, Nantes
CHU Bordeaux - Hopital Haut-Leveque - Centre François Magendie, Pessac
HCL Centre Hospitalier Lyon Sud, Pierre-Bénite
University Hospital of West Attica - Attikon - Hematology Division, Athens
ASST degli Spedali Civili di Brescia, Brescia
ASST di Monza-Ospedale San Gerardo, Monza
Fondazione Monza e Brianza per il Bambino e la sua Mamma, Monza
Fondazione IRCCS Policlinico San Matteo, Pavia
AOU Citta della Salute e della Scienza di Torino - Ospedale Regina Margherita, Torino
Citta della Salute e della Scienza di Torino - Ospedale le Molinette, Torino
Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE, Porto
Singapore General Hospital, Singapore
Pusan National University Hospital, Busan
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Hospital Universitario Donostia, Donostia / San Sebastian
Hospital Universitario Puerta de Hierro, Majadahonda
Hospital Universitario Marquis de Valdecilla, Santander
University Hospital of Wales, Cardiff
Queen Elizabeth University Hospital, Glasgow
Hammersmith Hospital, London
King's College Hospital NHS Foundation Trust, London
Royal Marsden Foundation Trust, London
Vancouver Coastal Health Authority, Vancouver
McGill University Health Center - Research Institute, Montreal
CHU Sainte-Justine, Montreal
Universitaetsklinikum Carl Gustav Carus Dresden, Dresden
Universitaetsklinikum Jena, Jena
Universitaetsklinikum Leipzig, Leipzig
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Oddzial w Gliwicach - Klinika Transplantacji Szpiku i Onkohematologii, Gliwice
Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E. (IPO-Lisboa), Lisbon
Hospital Universitario Vall d'Hebron, Barcelona
Bristol Royal Hospital for Children, Bristol
Lead Sponsor
Syndax Pharmaceuticals
INDUSTRY